In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...

Evercore ISI analyst Amit Daryanani maintained a Buy rating on Vertiv Holdings (VRT – Research Report) yesterday and set a price target of ...

Capital One Financial Corp (COF) shares attracted investor attention Wednesday morning after Evercore ISI upgraded the stock ...

Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on ...

Evercore ISI upgraded Capital One Financial Corp (NYSE:COF) to "Outperform" from "In Line," focusing on long-term earnings upside from its pending acquisition of Discover Financial Services (NYSE:DFS) ...

Capital One Financial (NYSE:COF) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an ...

Evercore ISI upgraded Capital One Financial to Outperform from In Line, bolstered by the conviction that the bank's ...

Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Stocks remained on track for their worst week since September, but were headed for a higher close in Friday's session, after ...

Evercore ISI analysts warned in a note Monday that stagflation fears are mounting, with tariff policies and economic uncertainty creating potential downside risks for the S&P 500.

Evercore ISI analyst Chris McNally has lowered EV giant Tesla’s price target from $270 to $235, citing ongoing market concerns and company-specific challenges. The price downgra ...

Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. As of March 4, 2025, the average one-year ...